First Total Synthesis of Cyrmenin B1
SCHEME 5
chromatography (20% EtOAc/ hexane) to afford 25 (3.96 g, 98%)
as a yellow oil. Rf ) 0.53 (30% EtOAc in hexane). 1H NMR
(CDCl3) δ: 5.45-5.65 (m, 2H), 4.16 (d, J ) 6.1 Hz, 2H), 2.35
(brs, 1H), 2.05 (dt, J ) 6.7, 7.0 Hz, 2H), 1.12-1.45 (m, 10H),
0.87 (t, J ) 7.0 Hz, 3H). 13C NMR (CDCl3) δ: 133.0, 128.5, 58.5,
31.9, 29.7, 29.3, 29.2, 27.5, 22.7, 14.1. HRMS (ESI+) calcd for
C10H20ONa [M + Na]+ 179.1406; found 179.1403.
(Z)-Dec-2-enal (26). Alcohol 25 (2.5 g, 15.9 mmol) was
dissolved in DMSO (41 mL), and IBX (6.71 g, 23.9 mmol) was
added. The resulting mixture was stirred for 2 h at rt. Water was
added (30 mL), and the mixture was stirred for 5 min. The
precipitate was filtered through a Celite pad, and the filtrate was
extracted with Et2O (3 × 75 mL). The combined organic layer was
dried over Na2SO4, filtered, and concentrated to afford 26 (2.43 g,
98%) as a yellow liquid, which was used for the next reaction
1
without purification. Rf ) 0.7 (10% EtOAc in hexane). H NMR
showed the presence of about 10% E isomer. 1H NMR (CDCl3) δ:
10.08 (d, J ) 8.2 Hz, 1H), 6.62 (dt, J ) 8.9, 7.2 Hz, 1H), 5.92 (dd,
J ) 8.2, 8.9 Hz, 1H), 2.58 (dt, J ) 7.2, 7.1 Hz, 2H), 1.40-1.50
(m, 2H), 1.20-1.40 (m, 8H), 0.87 (t, J ) 7.0 Hz, 3H). 13C NMR
(CDCl3) δ: 191.1, 153.7, 130.3, 31.8, 29.3, 29.1, 28.1, 22.7, 14.2.
HRMS (ESI+) calcd for C10H18ONa [M + Na]+ 177.1250; found
177.1255.
(2E,4Z)-3-Hydroxy-2-(2-methyldodeca-2,4-dienoylamino)-
propionic Acid Methyl Ester (29). Compound 28 (Supporting
Information, 1.70 g, 8.09 mmol) was dissolved in THF (150 mL),
BOP (3.94 g, 8.90 mmol), and serine methyl ester hydrochloride
(1.25 g, 8.09 mmol), and the resulting suspension was treated with
iPr2NEt (3.05 mL, 17.82 mmol) and stirred for 3.5 h at rt. The
organic solvent was removed under reduced pressure. The residue
was dissolved in EtOAc (200 mL) and washed with 1 N HCl, water,
saturated aqueous NaHCO3, water, and saturated aqueous NaCl.
The organic layer was dried over anhydrous Na2SO4, filtered, and
concentrated, and then the residue was purified by flash chroma-
tography to afford 29 (2.39 g, 95%) as a pale yellow solid. Mp: 38
same pathway starting from acid 28, with the 2E,4Z-configu-
ration. A stereocontrolled approach was developed to prepare
this intermediate (Scheme 5).
Alkylation of the dianion of propargyl alcohol with 1-bro-
moheptane gave dec-2-yn-1-ol 24,16 which was hydrogenated
in the presence of the Lindlar catalyst to afford quantitatively
(2Z)-dec-2-en-1-ol 25 as a single product. Oxidation with IBX
to aldehyde 26 (ratio E/Z, 1:10) followed by stereoselective
Horner-Wadsworth-Emmons olefination gave (2E,4Z) ester
27 in 82% yield, after column purification. The ester then was
hydrolyzed to the expected acid 28. The remaining steps of the
synthesis followed the pathway already described for the
8E,10E-isomer of cyrmenin B1 (Scheme 6).
No stereomutation of the olefinic bond of the original dienoate
28 had occurred at any stage of the synthesis, as confirmed by
1H spectroscopy. The final compound, obtained in 14 steps with
an overall yield of about 5%, completely matched natural
cyrmenin B1 in all spectroscopical properties and in the
antifungal activity against some selected fungal strains. Evalu-
ation of the antifungal activity of cyrmenin isomer 2b is in
progress.
In summary, the first total synthesis of cyrmenin B1 was
designed and carried out. Crucial steps for our strategy included
the formation of the dehydroalanine moiety from the corre-
sponding serine acetate and the formation of the ꢀ-methoxy-
acrylate moiety via trimethylsilyldiazomethane methylation of
the corresponding ꢀ-hydroxy enamide. Because of the modular
nature of our synthetic strategy, ready access to partial structures
and preparation of congeners and analogues is available.
1
°C. Rf ) 0.55 (75% EtOAc in hexane). H NMR (CDCl3) δ: 7.29
(d, J ) 10.9 Hz, 1H), 6.82 (d, J ) 5.91 Hz, 1H), 6.25 (dd, J )
10.9, 10.4 Hz), 5.78 (dt, J ) 10.4, 8.9 Hz, 1H), 4.62-4.70 (m,
1H), 3.90-4.10 (m, 2H), 3.76 (s, 3H), 2.25 (dt, J ) 8.77, 7.44 Hz,
2H), 1.95 (s, 3H), 1.30-1.50 (m, 10H), 0.90 (t, J ) 7.4 Hz, 3H).
13C NMR (CDCl3) δ: 171.3, 169.6, 139.8, 130.1, 128.4, 123.3, 63.2,
55.2, 52.7, 31.8, 29.5, 29.2, 28.2, 22.7, 14.1, 12.6. HRMS (ESI+)
calcd for C17H29NO4Na [M + Na]+ 334.1989; found 334.1985.
2-[3-(tert-Butyl-diphenyl-silanyloxy)-2-((2E,4Z)-2-methyl-
dodeca-2,4-dienoylamino)-propionylamino]-3-hydroxy-propi-
onic Acid Methyl Ester (32). Ice-cooled aqueous LiOH ·H2O
(0.426 g, 10.1 mmol) in water (24 mL) was added dropwise to the
rapidly stirred solution of ester 30 (Supporting Information, 2.80 g,
5.09 mmol) in THF (73 mL) at 0 °C. The reaction mixture was
stirred at 0 °C for 5 min, then warmed to rt and stirred for 1 h. The
reaction mixture was cooled to 0 °C, and ice-cooled 1 M HCl was
added dropwise to the rapidly stirred solution causing the solution
to become cloudy. The reaction mixture was partitioned between
aqueous NaCl (30 mL) and EtOAc (40 mL), and the layers were
separated. The aqueous layer was extracted with EtOAc (3 × 40
mL). The combined organic layer was dried over Na2SO4, filtered,
and concentrated to afford 31 as white crude solid (2.69 g, 99%),
which was used for the next reaction without purification. Rf )
0.59 (50% EtOAc in hexane). A mixture of 31 (1.74 g, 3.25 mmol)
and serine methyl ester hydrochloride (0.60 g, 3.91 mmol) in THF
(90 mL) was treated with BOP (1.73 g, 3.91 mmol) and iPr2NEt
(1.22 mL, 7.17 mmol) at 0 °C. The resulting reaction mixture was
stirred for 3 h at rt. The organic solvent was removed under reduced
pressure, and the residue was dissolved in EtOAc (250 mL) and
washed with aqueous HCl (pH ≈ 5), water, saturated aqueous
NaHCO3, water, and brine. The organic layer was dried over
anhydrous Na2SO4, filtered, and concentrated, and the residue was
purified by flash chromatography (43% EtOAc in hexane) to give
32 (1.10 g, 53%) as a white solid. Mp: 126 °C. Rf ) 0.67 (70%
Experimental Section
(Z)-Dec-2-en-1-ol (25). A mixture of dec-2-yn-1-ol (24) (4 g,
1.0 mmol), EtOH (78 mL), pyridine (13 mL), and Lindlar catalyst
(444 mg) was stirred at rt under a hydrogen gas atmosphere for
1 h. The mixture was filtered through a Celite pad. The filtrate was
concentrated to obtain crude product which was purified by column
(16) Yoshida, T.; Murai, M.; Abe, M.; Ichimaru, N.; Harada, T.; Nishioka,
T.; Miyoshi, H. Biochemistry 2007, 46, 10365–10372.
J. Org. Chem. Vol. 74, No. 2, 2009 847